StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) income statement

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.81−0.09 (-2.31%)

Close on Nov 18, 2026Market cap $43.25MP/E –Yield –

See a number that looks wrong?